Jiangsu Hualan Stock Hits Day High with 3.13% Surge

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. has experienced a notable increase of 3.13% on March 27, 2026, reaching an intraday high of CNY 88.66. This performance stands out against the backdrop of the China Shanghai Composite, which recorded a modest gain of 0.63% on the same day. Over the past month, Jiangsu Hualan has shown a robust performance with a 12.14% increase, significantly outperforming the China Shanghai Composite, which declined by 5.99%. Year-to-date, the stock has surged by 72.86%, while the broader index has faced a slight downturn of 1.39%. Impressively, the stock has delivered a remarkable 298.3% return over the past year, contrasting sharply with the 16.01% gain of the China Shanghai Composite. Despite these gains, the company faces challenges, including a low Return on Capital Employed (ROCE) of 9.64% and declining net sales over the past five years. The market capitalization stands at CNY 12,456 million, reflecting its large-cap status in the packaging industry.